|
|
Article: Strategic Relationships Between Outsourcers and Drug Discovery Contract Research Organizations Improve Productivity.
- Article from:
- Business Wire
- Article date:
- October 6, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
PALO ALTO, Calif.--(BUSINESS WIRE)--Oct. 6, 2003
In a marked departure from the custom of outsourcing drug discovery needs simply to resolve a shortage in resources, pharmaceutical and biotech companies have begun to form strategic relations with drug discovery contract research companies. This is expected to alleviate some pressure on them to improve research productivity.
New analysis from Frost & Sullivan (www.healthcare.frost.com), "Drug Discovery Contract Research Markets: Profiles of the Top 50 Global Outsourcers," reveals that management of the drug discovery process and technologies provides ...